(Q39750234)

14 September 2017

Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles (English)

1 reference

14 September 2017

0 references

0 references

1 reference

A L Svingos

1

1 reference

14 September 2017

C Chavkin

series ordinal

2

1 reference

14 September 2017

E E Colago

series ordinal

3

1 reference

14 September 2017

V M Pickel

series ordinal

4

1 reference

14 September 2017

1 December 2001

1 reference

14 September 2017

1 reference

14 September 2017

42

1 reference

14 September 2017

3

1 reference

14 September 2017

185-192

1 reference

Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.

14 September 2017

1 reference

Light microscopic morphometric analysis of peroxisomes by automatic image analysis: advantages of immunostaining over the alkaline DAB method

21 January 2018

1 reference

Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding

21 January 2018

1 reference

Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor

21 January 2018

1 reference

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

Kappa opioid receptor-like immunoreactivity in guinea pig brain: ultrastructural localization in presynaptic terminals in hippocampal formation

21 January 2018

1 reference

U-50,488H inhibits dynorphin and glutamate release from guinea pig hippocampal mossy fiber terminals

21 January 2018

1 reference

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

21 January 2018

1 reference

Kappa opioid inhibition of morphine and cocaine self-administration in rats

21 January 2018

1 reference

The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum

21 January 2018

1 reference

The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat.

21 January 2018

1 reference

Synaptic organization of immunocytochemically identified GABA neurons in the monkey sensory-motor cortex

21 January 2018

1 reference

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

21 January 2018

1 reference

Cellular and molecular mechanisms of drug dependence

21 January 2018

1 reference

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats

21 January 2018

1 reference

Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition.

21 January 2018

1 reference

Kappa opioid receptor immunoreactivity in the nucleus accumbens and caudate-putamen is primarily associated with synaptic vesicles in axons

21 January 2018

1 reference

Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine

21 January 2018

1 reference

Substance P in the rat nucleus accumbens: ultrastructural localization in axon terminals and their relation to dopaminergic afferents.

21 January 2018

1 reference

The use of lead citrate at high pH as an electron-opaque stain in electron microscopy

21 January 2018

1 reference

U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking

21 January 2018

1 reference

Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists

21 January 2018

1 reference

Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593.

21 January 2018

1 reference

Involvement of mesolimbic kappa-opioid systems in the discriminative stimulus effects of morphine

21 January 2018

1 reference

The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study

21 January 2018

1 reference

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

21 January 2018

1 reference

Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior

21 January 2018

1 reference

Vesicular acetylcholine transporter in the rat nucleus accumbens shell: subcellular distribution and association with mu-opioid receptors

21 January 2018

1 reference

Neurobiology of cocaine abuse

21 January 2018

1 reference

Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum

21 January 2018

1 reference

U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine.

21 January 2018

1 reference

Immunocytochemical localization of the alpha 1 and beta 2/3 subunits of the GABAA receptor in relation to specific GABAergic synapses in the dentate gyrus

21 January 2018

1 reference

Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum.

21 January 2018

1 reference

Sympathetic axons and nerve terminals: the protein composition of small and large dense-core and of a third type of vesicles

21 January 2018

1 reference

L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells

21 January 2018

1 reference

Dynorphin-immunoreactive neurons in the rat nucleus accumbens: ultrastructure and synaptic input from terminals containing substance P and/or dynorphin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SYN.10005

1 reference

14 September 2017

1 reference